Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 233 across all filing types
Latest filing 2026-05-14 Earnings Release
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 92% confidence The document is a press release to the stock exchanges announcing the audited financial results for Q4 FY26 and the full year ended 31 March 2026. It provides key financial metrics (revenue, EBITDA, PAT), YoY growth, management commentary, and details of the upcoming earnings call. This aligns with the definition of an Earnings Release (ER) as the initial announcement of quarterly/periodical financial results. FY 2026
2026-05-14 English
Press Release for the Financial Results for the quarter and year ended 31 March 2026.
Earnings Release Classification · 95% confidence The document is a press release addressed to stock exchanges announcing the audited financial results for Q4 and full year ended 31 March 2026, including headline metrics (revenue, EBITDA, PAT) and key highlights, followed by details for an upcoming earnings call. This matches the definition of an Earnings Release (initial announcement of periodical financial results, key highlights only). FY 2026
2026-05-14 English
Audited Financial Results for the year ended 31 March, 2026
Interim / Quarterly Report Classification · 82% confidence The document is the Company’s board meeting outcome announcing and providing the full audited financial results (standalone P&L, balance sheet, cash flow, and notes) for the quarter and year ended March 31, 2026. This is a regulatory interim/quarterly financial report rather than a high‐level highlights-only earnings release or a full Annual Report (10-K). It contains substantive financial statements as required under SEBI LODR regulations, fitting the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-14 English
Outcome of Board Meeting
Regulatory Filings Classification · 72% confidence The document is a regulatory announcement under SEBI Listing Regulations 2015 of the Board meeting outcome and audited financial results for the quarter and year ended March 31, 2026. It contains full financial statements (income statement, balance sheet, cash flows, notes) rather than a full narrative annual report (10-K), a standalone audit opinion (AR), or a simple earnings highlight (ER). It is a mandated regulatory filing and falls into the fallback “Regulatory Filings” category (RNS).
2026-05-14 English
Considered and Approved the Audited Financial Results for the Financial Year ended 31st March, 2026.
Interim / Quarterly Report Classification · 87% confidence The document is the formal Board Meeting outcome announcing and enclosing the audited standalone financial results for the quarter and year ended 31 March 2026. It includes full financial statements (income statement, balance sheet, cash flow, notes) rather than just highlights or a link to a report. This is a substantive interim/quarterly (and fourth-quarter) financial report as per Regulation 33 of SEBI LODR. Under our taxonomy, this falls under Interim / Quarterly Report (IR), not merely an earnings release or publication notice. FY 2026
2026-05-14 English
Intimation for Achievement of 100% renewal Power at Bidar Campus of the Company.
Regulatory Filings Classification · 86% confidence The document is a press release filed under Regulation 30 of SEBI’s Listing Obligations (a compliance announcement to the stock exchanges) highlighting a sustainability milestone. It does not contain substantive financial statements or constitute a detailed ESG report; rather, it is a general regulatory announcement. Therefore, under our taxonomy it is classified as a Regulatory Filing (RNS).
2026-05-11 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.